CHEBI:142623 - spiroiminodihydantoin

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name spiroiminodihydantoin
ChEBI ID CHEBI:142623
Definition An azaspiro compound that is 1,3,6,8-tetraazaspiro[4.4]non-6-ene which is substituted by oxo groups at positions 2, 4, and 9. Both enantiomers are highly mutagenic products resulting from the oxidation of guanine and 8-oxo-7,8-dihydroguanine in DNA by reactive oxygen species.
Stars This entity has been manually annotated by the ChEBI Team.
Submitter Marija
Supplier Information
Download Molfile XML SDF
more structures >>
Formula C5H5N5O3
Net Charge 0
Average Mass 183.125
Monoisotopic Mass 183.03924
InChI InChI=1S/C5H5N5O3/c6-3-7-1(11)5(9-3)2(12)8-4(13)10-5/h(H3,6,7,9,11)(H2,8,10,12,13)
InChIKey HJWQNCPSKFANJK-UHFFFAOYSA-N
SMILES N1C(NC(C12N=C(NC2=O)N)=O)=O
Roles Classification
Biological Role(s): mutagen
An agent that increases the frequency of mutations above the normal background level, usually by interacting directly with DNA and causing it damage, including base substitution.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing spiroiminodihydantoin (CHEBI:142623) has functional parent hydantoin (CHEBI:27612)
spiroiminodihydantoin (CHEBI:142623) has role mutagen (CHEBI:25435)
spiroiminodihydantoin (CHEBI:142623) is a azaspiro compound (CHEBI:35624)
IUPAC Name
7-amino-1,3,6,8-tetraazaspiro[4.4]non-6-ene-2,4,9-trione
Citations Waiting for Citations Types Sources
15540949 PubMed citation Europe PMC
17915881 PubMed citation Europe PMC
19146379 PubMed citation Europe PMC
19485408 PubMed citation Europe PMC
20014751 PubMed citation Europe PMC
23360616 PubMed citation Europe PMC
24649945 PubMed citation Europe PMC
26572218 PubMed citation Europe PMC
26807878 PubMed citation Europe PMC
27074396 PubMed citation Europe PMC
28230976 PubMed citation Europe PMC
28514164 PubMed citation Europe PMC
28845978 PubMed citation Europe PMC
30592213 PubMed citation Europe PMC
Last Modified
21 January 2019